Global T Cell Surface Glycoprotein CD4 Market Growth 2025-2031

October 2025 | 99 pages | ID: G54B1FE948FAEN
LP Information

Abstracts

The global T Cell Surface Glycoprotein CD4 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for T Cell Surface Glycoprotein CD4 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for T Cell Surface Glycoprotein CD4 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for T Cell Surface Glycoprotein CD4 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key T Cell Surface Glycoprotein CD4 players cover Biotest AG, Bristol-Myers Squibb Co, CEL-SCI Corp, Fountain Biopharma Inc, Immupharma Plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?T Cell Surface Glycoprotein CD4 Industry Forecast? looks at past sales and reviews total world T Cell Surface Glycoprotein CD4 sales in 2024, providing a comprehensive analysis by region and market sector of projected T Cell Surface Glycoprotein CD4 sales for 2025 through 2031. With T Cell Surface Glycoprotein CD4 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world T Cell Surface Glycoprotein CD4 industry.

This Insight Report provides a comprehensive analysis of the global T Cell Surface Glycoprotein CD4 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on T Cell Surface Glycoprotein CD4 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global T Cell Surface Glycoprotein CD4 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for T Cell Surface Glycoprotein CD4 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global T Cell Surface Glycoprotein CD4.

This report presents a comprehensive overview, market shares, and growth opportunities of T Cell Surface Glycoprotein CD4 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Forigerimod Acetate
• HIV Vaccine 2
• Ibalizumab
• Others

Segmentation by Application:

• HIV
• AIDS
• GVHD
• SARS
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Biotest AG
• Bristol-Myers Squibb Co
• CEL-SCI Corp
• Fountain Biopharma Inc
• Immupharma Plc
• Sanofi
• TaiMed Biologics Inc
• United Biomedical Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global T Cell Surface Glycoprotein CD4 market?
What factors are driving T Cell Surface Glycoprotein CD4 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do T Cell Surface Glycoprotein CD4 market opportunities vary by end market size?
How does T Cell Surface Glycoprotein CD4 break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global T Cell Surface Glycoprotein CD4 Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for T Cell Surface Glycoprotein CD4 by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for T Cell Surface Glycoprotein CD4 by Country/Region, 2020, 2024 & 2031
2.2 T Cell Surface Glycoprotein CD4 Segment by Type
  2.2.1 Forigerimod Acetate
  2.2.2 HIV Vaccine 2
  2.2.3 Ibalizumab
  2.2.4 Others
2.3 T Cell Surface Glycoprotein CD4 Sales by Type
  2.3.1 Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2020-2025)
  2.3.2 Global T Cell Surface Glycoprotein CD4 Revenue and Market Share by Type (2020-2025)
  2.3.3 Global T Cell Surface Glycoprotein CD4 Sale Price by Type (2020-2025)
2.4 T Cell Surface Glycoprotein CD4 Segment by Application
  2.4.1 HIV
  2.4.2 AIDS
  2.4.3 GVHD
  2.4.4 SARS
  2.4.5 Others
2.5 T Cell Surface Glycoprotein CD4 Sales by Application
  2.5.1 Global T Cell Surface Glycoprotein CD4 Sale Market Share by Application (2020-2025)
  2.5.2 Global T Cell Surface Glycoprotein CD4 Revenue and Market Share by Application (2020-2025)
  2.5.3 Global T Cell Surface Glycoprotein CD4 Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global T Cell Surface Glycoprotein CD4 Breakdown Data by Company
  3.1.1 Global T Cell Surface Glycoprotein CD4 Annual Sales by Company (2020-2025)
  3.1.2 Global T Cell Surface Glycoprotein CD4 Sales Market Share by Company (2020-2025)
3.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue by Company (2020-2025)
  3.2.1 Global T Cell Surface Glycoprotein CD4 Revenue by Company (2020-2025)
  3.2.2 Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Company (2020-2025)
3.3 Global T Cell Surface Glycoprotein CD4 Sale Price by Company
3.4 Key Manufacturers T Cell Surface Glycoprotein CD4 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers T Cell Surface Glycoprotein CD4 Product Location Distribution
  3.4.2 Players T Cell Surface Glycoprotein CD4 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR T CELL SURFACE GLYCOPROTEIN CD4 BY GEOGRAPHIC REGION

4.1 World Historic T Cell Surface Glycoprotein CD4 Market Size by Geographic Region (2020-2025)
  4.1.1 Global T Cell Surface Glycoprotein CD4 Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic T Cell Surface Glycoprotein CD4 Market Size by Country/Region (2020-2025)
  4.2.1 Global T Cell Surface Glycoprotein CD4 Annual Sales by Country/Region (2020-2025)
  4.2.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue by Country/Region (2020-2025)
4.3 Americas T Cell Surface Glycoprotein CD4 Sales Growth
4.4 APAC T Cell Surface Glycoprotein CD4 Sales Growth
4.5 Europe T Cell Surface Glycoprotein CD4 Sales Growth
4.6 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Growth

5 AMERICAS

5.1 Americas T Cell Surface Glycoprotein CD4 Sales by Country
  5.1.1 Americas T Cell Surface Glycoprotein CD4 Sales by Country (2020-2025)
  5.1.2 Americas T Cell Surface Glycoprotein CD4 Revenue by Country (2020-2025)
5.2 Americas T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025)
5.3 Americas T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC T Cell Surface Glycoprotein CD4 Sales by Region
  6.1.1 APAC T Cell Surface Glycoprotein CD4 Sales by Region (2020-2025)
  6.1.2 APAC T Cell Surface Glycoprotein CD4 Revenue by Region (2020-2025)
6.2 APAC T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025)
6.3 APAC T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe T Cell Surface Glycoprotein CD4 by Country
  7.1.1 Europe T Cell Surface Glycoprotein CD4 Sales by Country (2020-2025)
  7.1.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2020-2025)
7.2 Europe T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025)
7.3 Europe T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa T Cell Surface Glycoprotein CD4 by Country
  8.1.1 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Country (2020-2025)
  8.1.2 Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue by Country (2020-2025)
8.2 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025)
8.3 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of T Cell Surface Glycoprotein CD4
10.3 Manufacturing Process Analysis of T Cell Surface Glycoprotein CD4
10.4 Industry Chain Structure of T Cell Surface Glycoprotein CD4

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 T Cell Surface Glycoprotein CD4 Distributors
11.3 T Cell Surface Glycoprotein CD4 Customer

12 WORLD FORECAST REVIEW FOR T CELL SURFACE GLYCOPROTEIN CD4 BY GEOGRAPHIC REGION

12.1 Global T Cell Surface Glycoprotein CD4 Market Size Forecast by Region
  12.1.1 Global T Cell Surface Glycoprotein CD4 Forecast by Region (2026-2031)
  12.1.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global T Cell Surface Glycoprotein CD4 Forecast by Type (2026-2031)
12.7 Global T Cell Surface Glycoprotein CD4 Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Biotest AG
  13.1.1 Biotest AG Company Information
  13.1.2 Biotest AG T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.1.3 Biotest AG T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Biotest AG Main Business Overview
  13.1.5 Biotest AG Latest Developments
13.2 Bristol-Myers Squibb Co
  13.2.1 Bristol-Myers Squibb Co Company Information
  13.2.2 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.2.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bristol-Myers Squibb Co Main Business Overview
  13.2.5 Bristol-Myers Squibb Co Latest Developments
13.3 CEL-SCI Corp
  13.3.1 CEL-SCI Corp Company Information
  13.3.2 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.3.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 CEL-SCI Corp Main Business Overview
  13.3.5 CEL-SCI Corp Latest Developments
13.4 Fountain Biopharma Inc
  13.4.1 Fountain Biopharma Inc Company Information
  13.4.2 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.4.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Fountain Biopharma Inc Main Business Overview
  13.4.5 Fountain Biopharma Inc Latest Developments
13.5 Immupharma Plc
  13.5.1 Immupharma Plc Company Information
  13.5.2 Immupharma Plc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.5.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Immupharma Plc Main Business Overview
  13.5.5 Immupharma Plc Latest Developments
13.6 Sanofi
  13.6.1 Sanofi Company Information
  13.6.2 Sanofi T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.6.3 Sanofi T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Sanofi Main Business Overview
  13.6.5 Sanofi Latest Developments
13.7 TaiMed Biologics Inc
  13.7.1 TaiMed Biologics Inc Company Information
  13.7.2 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.7.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 TaiMed Biologics Inc Main Business Overview
  13.7.5 TaiMed Biologics Inc Latest Developments
13.8 United Biomedical Inc
  13.8.1 United Biomedical Inc Company Information
  13.8.2 United Biomedical Inc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
  13.8.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 United Biomedical Inc Main Business Overview
  13.8.5 United Biomedical Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. T Cell Surface Glycoprotein CD4 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. T Cell Surface Glycoprotein CD4 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Forigerimod Acetate
Table 4. Major Players of HIV Vaccine 2
Table 5. Major Players of Ibalizumab
Table 6. Major Players of Others
Table 7. Global T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025) & (K Pcs)
Table 8. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2020-2025)
Table 9. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2020-2025) & ($ million)
Table 10. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2020-2025)
Table 11. Global T Cell Surface Glycoprotein CD4 Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global T Cell Surface Glycoprotein CD4 Sale by Application (2020-2025) & (K Pcs)
Table 13. Global T Cell Surface Glycoprotein CD4 Sale Market Share by Application (2020-2025)
Table 14. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2020-2025) & ($ million)
Table 15. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2020-2025)
Table 16. Global T Cell Surface Glycoprotein CD4 Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global T Cell Surface Glycoprotein CD4 Sales by Company (2020-2025) & (K Pcs)
Table 18. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Company (2020-2025)
Table 19. Global T Cell Surface Glycoprotein CD4 Revenue by Company (2020-2025) & ($ millions)
Table 20. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Company (2020-2025)
Table 21. Global T Cell Surface Glycoprotein CD4 Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers T Cell Surface Glycoprotein CD4 Producing Area Distribution and Sales Area
Table 23. Players T Cell Surface Glycoprotein CD4 Products Offered
Table 24. T Cell Surface Glycoprotein CD4 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global T Cell Surface Glycoprotein CD4 Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global T Cell Surface Glycoprotein CD4 Sales Market Share Geographic Region (2020-2025)
Table 29. Global T Cell Surface Glycoprotein CD4 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global T Cell Surface Glycoprotein CD4 Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Country/Region (2020-2025)
Table 33. Global T Cell Surface Glycoprotein CD4 Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas T Cell Surface Glycoprotein CD4 Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2020-2025)
Table 37. Americas T Cell Surface Glycoprotein CD4 Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC T Cell Surface Glycoprotein CD4 Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2020-2025)
Table 42. APAC T Cell Surface Glycoprotein CD4 Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of T Cell Surface Glycoprotein CD4
Table 54. Key Market Challenges & Risks of T Cell Surface Glycoprotein CD4
Table 55. Key Industry Trends of T Cell Surface Glycoprotein CD4
Table 56. T Cell Surface Glycoprotein CD4 Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. T Cell Surface Glycoprotein CD4 Distributors List
Table 59. T Cell Surface Glycoprotein CD4 Customer List
Table 60. Global T Cell Surface Glycoprotein CD4 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas T Cell Surface Glycoprotein CD4 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC T Cell Surface Glycoprotein CD4 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC T Cell Surface Glycoprotein CD4 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global T Cell Surface Glycoprotein CD4 Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global T Cell Surface Glycoprotein CD4 Sales Forecast by Application (2026-2031) & (K Pcs)
Table 73. Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Biotest AG Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 75. Biotest AG T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 76. Biotest AG T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Biotest AG Main Business
Table 78. Biotest AG Latest Developments
Table 79. Bristol-Myers Squibb Co Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 80. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 81. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Bristol-Myers Squibb Co Main Business
Table 83. Bristol-Myers Squibb Co Latest Developments
Table 84. CEL-SCI Corp Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 85. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 86. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. CEL-SCI Corp Main Business
Table 88. CEL-SCI Corp Latest Developments
Table 89. Fountain Biopharma Inc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 90. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 91. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Fountain Biopharma Inc Main Business
Table 93. Fountain Biopharma Inc Latest Developments
Table 94. Immupharma Plc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 95. Immupharma Plc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 96. Immupharma Plc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Immupharma Plc Main Business
Table 98. Immupharma Plc Latest Developments
Table 99. Sanofi Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 101. Sanofi T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. TaiMed Biologics Inc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 105. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 106. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. TaiMed Biologics Inc Main Business
Table 108. TaiMed Biologics Inc Latest Developments
Table 109. United Biomedical Inc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors
Table 110. United Biomedical Inc T Cell Surface Glycoprotein CD4 Product Portfolios and Specifications
Table 111. United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. United Biomedical Inc Main Business
Table 113. United Biomedical Inc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of T Cell Surface Glycoprotein CD4
Figure 2. T Cell Surface Glycoprotein CD4 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global T Cell Surface Glycoprotein CD4 Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global T Cell Surface Glycoprotein CD4 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. T Cell Surface Glycoprotein CD4 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. T Cell Surface Glycoprotein CD4 Sales Market Share by Country/Region (2024)
Figure 10. T Cell Surface Glycoprotein CD4 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Forigerimod Acetate
Figure 12. Product Picture of HIV Vaccine 2
Figure 13. Product Picture of Ibalizumab
Figure 14. Product Picture of Others
Figure 15. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type in 2025
Figure 16. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2020-2025)
Figure 17. T Cell Surface Glycoprotein CD4 Consumed in HIV
Figure 18. Global T Cell Surface Glycoprotein CD4 Market: HIV (2020-2025) & (K Pcs)
Figure 19. T Cell Surface Glycoprotein CD4 Consumed in AIDS
Figure 20. Global T Cell Surface Glycoprotein CD4 Market: AIDS (2020-2025) & (K Pcs)
Figure 21. T Cell Surface Glycoprotein CD4 Consumed in GVHD
Figure 22. Global T Cell Surface Glycoprotein CD4 Market: GVHD (2020-2025) & (K Pcs)
Figure 23. T Cell Surface Glycoprotein CD4 Consumed in SARS
Figure 24. Global T Cell Surface Glycoprotein CD4 Market: SARS (2020-2025) & (K Pcs)
Figure 25. T Cell Surface Glycoprotein CD4 Consumed in Others
Figure 26. Global T Cell Surface Glycoprotein CD4 Market: Others (2020-2025) & (K Pcs)
Figure 27. Global T Cell Surface Glycoprotein CD4 Sale Market Share by Application (2024)
Figure 28. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application in 2025
Figure 29. T Cell Surface Glycoprotein CD4 Sales by Company in 2025 (K Pcs)
Figure 30. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Company in 2025
Figure 31. T Cell Surface Glycoprotein CD4 Revenue by Company in 2025 ($ millions)
Figure 32. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Company in 2025
Figure 33. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Geographic Region in 2025
Figure 35. Americas T Cell Surface Glycoprotein CD4 Sales 2020-2025 (K Pcs)
Figure 36. Americas T Cell Surface Glycoprotein CD4 Revenue 2020-2025 ($ millions)
Figure 37. APAC T Cell Surface Glycoprotein CD4 Sales 2020-2025 (K Pcs)
Figure 38. APAC T Cell Surface Glycoprotein CD4 Revenue 2020-2025 ($ millions)
Figure 39. Europe T Cell Surface Glycoprotein CD4 Sales 2020-2025 (K Pcs)
Figure 40. Europe T Cell Surface Glycoprotein CD4 Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue 2020-2025 ($ millions)
Figure 43. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2025
Figure 44. Americas T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2020-2025)
Figure 45. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2020-2025)
Figure 46. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2020-2025)
Figure 47. United States T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Region in 2025
Figure 52. APAC T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2020-2025)
Figure 53. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2020-2025)
Figure 54. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2020-2025)
Figure 55. China T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 59. India T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2025
Figure 63. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2020-2025)
Figure 64. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2020-2025)
Figure 65. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2020-2025)
Figure 66. Germany T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 67. France T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 68. UK T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2020-2025)
Figure 74. Egypt T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries T Cell Surface Glycoprotein CD4 Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of T Cell Surface Glycoprotein CD4 in 2025
Figure 80. Manufacturing Process Analysis of T Cell Surface Glycoprotein CD4
Figure 81. Industry Chain Structure of T Cell Surface Glycoprotein CD4
Figure 82. Channels of Distribution
Figure 83. Global T Cell Surface Glycoprotein CD4 Sales Market Forecast by Region (2026-2031)
Figure 84. Global T Cell Surface Glycoprotein CD4 Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global T Cell Surface Glycoprotein CD4 Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global T Cell Surface Glycoprotein CD4 Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global T Cell Surface Glycoprotein CD4 Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global T Cell Surface Glycoprotein CD4 Revenue Market Share Forecast by Application (2026-2031)